Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - Oncotelic Therapeutics, Inc. | Financial_Report.xls |
EX-32.1 - EX-32.1 - Oncotelic Therapeutics, Inc. | d847033dex321.htm |
EX-31.2 - EX-31.2 - Oncotelic Therapeutics, Inc. | d847033dex312.htm |
10-K - 10-K - Oncotelic Therapeutics, Inc. | d847033d10k.htm |
EX-31.1 - EX-31.1 - Oncotelic Therapeutics, Inc. | d847033dex311.htm |
EX-14.1 - EX-14.1 - Oncotelic Therapeutics, Inc. | d847033dex141.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements of OXiGENE, Inc.:
1. | Registration Statement (Form S-1 No. 333-190464) of OXiGENE, Inc., |
2. | Registration Statements (Form S-3 Nos. 333-196589, 333-191531, 333-188114, 333-181813, 333-155372, 333-128528, 333-106307, 333-109433, 333-160976 and 333-165826) of OXiGENE, Inc., |
3. | Registration Statement (Form S-8 No. 333-05787) pertaining to the Amended and Restated Stock Incentive Plan of OXiGENE, Inc., |
4. | Registration Statements (Form S-8 Nos. 333-92747, 333-32958 and 333-117083) pertaining to the 1996 Stock Incentive Plan of OXiGENE, Inc., |
5. | Registration Statement (Form S-8 No. 333-84870) pertaining to the Compensation Award Stock Agreements between Registrant and Certain Directors of OXiGENE, Inc., |
6. | Registration Statement (Form S-8 No. 333-85860) pertaining to the Compensation Award Stock Agreement between Registrant and a Company Director of OXiGENE, Inc., |
7. | Registration Statement (Form S-8 No. 333-84872) pertaining to the Restricted Stock Agreements between Registrant and Certain Employees and Non-Employees of OXiGENE, Inc., |
8. | Registration Statement (Form S-8 Nos. 333-126636, 333-181810 and 333-190409) pertaining to the OXiGENE, Inc. 2005 Stock Plan, as amended. |
9. | Registration Statement (Form S-8 No. 333-159585) pertaining to the OXiGENE, Inc. 2005 Stock Plan and the OXiGENE, Inc. 2009 Employee Stock Purchase Plan of OXiGENE, Inc., |
10. | Registration Statement (Form S-8 No. 333-177628) pertaining to the OXiGENE, Inc. 2005 Stock Plan and the OXiGENE, Inc. 2009 Employee Stock Purchase Plan, |
and in the related Prospectuses of our report dated March 30, 2015, with respect to the financial statements of OXiGENE, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2014.
/s/ Ernst & Young LLP
San Jose, California
March 30, 2015